Anonymous
Guest
Anonymous
Guest
Oncology cut by 35% in November, then HCV, 50% cut in Neuro and now opthomology completely gone. But we still have hospital tablet reps (unbelievable) and lots and lots of highly paid MGAMS! Really??
Oncology cut by 35% in November, then HCV, 50% cut in Neuro and now opthomology completely gone. But we still have hospital tablet reps (unbelievable) and lots and lots of highly paid MGAMS! Really??
In this economy, I don't see how Merck can continue to support the MGAM role. It just doesn't make good business sense.
In this economy, I don't see how Merck can continue to support the MGAM role. It just doesn't make good business sense.
Oncology cut by 35% in November, then HCV, 50% cut in Neuro and now opthomology completely gone. But we still have hospital tablet reps (unbelievable) and lots and lots of highly paid MGAMS! Really??
good business sense?? are you kidding me?? What in the world does Merck do on a routine basis that makes any sense at all...
It is called corruption my friend...Managers will always provide corporate welfare for other managers...
Let's look at how the MGAM role originally came about...It was to create a safe haven for district managers that were no longer needed...God forbid you get rid of these people...NO!!! Let's create a safety net for all displaced managers and call them MGAMs...
They will make one or two calls per month on the accounts, have tons of teleconferences, and steal ideas from the reps they come in contact with...Nice gig if you can get it...
Shameful for the company and its stockholders.